Virtual Workshop B — From Evidence to Reimbursement—Stress-Testing a Canadian HTA Submission

Mar 2, 2027 1:00 pm – 4:00 pm

A promising medicine may face significant assessment and reimbursement challenges when its clinical evidence, economic evaluation or budget impact analysis does not adequately address Canadian HTA requirements and payer expectations. In this hands-on workshop, participants will examine a simulated submission for a hypothetical medicine, exploring how evidence quality, economic assumptions and uncertainty can influence HTA recommendations and subsequent reimbursement decisions.

  • Applying HTA assessment principles to identify submission strengths and weaknesses
  • Prioritizing evidence gaps and areas requiring further consideration
  • Interpreting how uncertainty influences HTA recommendations and reimbursement considerations
  • Exploring how different stakeholders can address evidence gaps and support informed reimbursement decisions